ClinicalTrials.gg
Drug

Topotecan clinical trials

Also written Hycamtin, hycamptamine, Hycamptin and SKF-104864.

studies test it
251
open now
17
in phase 3
26
first study started
1993

How each study uses Topotecan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Topotecan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 May 1996 · HYCAMTIN · NDA 020671 (FDA, Drugs@FDA)
European Union
12 Nov 1996 · Hycamtin · EMEA/H/C/000123 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Topotecan
119
topotecan hydrochloride
111
SKF S-104864-A
16
TOPO
12
Topotecan HCl
5

Brand

Hycamtin
66
Hycamptin
3

Development codes

SKF-104864
3

Other names

hycamptamine
20

Studies by the year they started

246 studies that test it; most in 2004 (23)

Studies that test Topotecan, by start year
YearStudies
19932
19942
19953
19967
19979
199814
199917
200011
200115
200214
20038
200423
200515
200614
200714
200812
20099
20101
20112
20122
20134
20143
20157
20166
20171
20183
20192
20202
20213
20223
20236
20244
20255
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
6
Phase 1
107
Phase 2
128
Phase 3
26
Phase 4
1
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 33 · Other 218

National Cancer Institute (NCI) (17) · GlaxoSmithKline (17) · H. Lee Moffitt Cancer Center and Research Institute (11) · Gynecologic Oncology Group (11) · SCRI Development Innovations, LLC (10) · Children's Oncology Group (9) · Alliance for Clinical Trials in Oncology (9) · St. Jude Children's Research Hospital (6)

Often tested with

Tested in the same studies.

Carboplatin (36) · Paclitaxel (33) · Cyclophosphamide (28) · Etoposide (27) · Cisplatin (23) · Doxorubicin (19) · Vincristine (13) · Temozolomide (12)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 29 phase 3 studies under way

Topotecan is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 7, 1 in phase 3

Studies that test Topotecan, phase 3 first.

Studies

Open first, then newest update. How each study uses Topotecan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 251

See all 251 studies that test Topotecan →

Given beside what is tested · 70 — Topotecan is usual care or a partner of the new treatment

Showing 20 of 70.

As the comparator · 65 — what is tested is compared with Topotecan

Showing 20 of 65.

Codes

What other systems call Topotecan · ClinicalTrials.gg INT008712

  • MeSH (NLM) D019772TopotecanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7M7YKX2N15TOPOTECANConfirmed FDA, NLM, Wikidata
  • RxNorm 57308Confirmed FDA, Wikidata
  • Wikidata Q419953topotecanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1413TopotecanOne source FDA
  • DrugBank DB01030One source Wikidata

Also registered as topotecan hydrochloride (UNII 956S425ZCY · RxNorm 266573).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.